glp1.how

reference

Patient assistance program

Updated Jul 14, 2026

Patient assistance programs (PAPs) are typically run by drug manufacturers or nonprofit organizations to provide medications at reduced or no cost to patients who meet income or insurance-status eligibility criteria. Manufacturers of GLP-1 medications often operate PAPs for uninsured or underinsured patients, separate from savings cards aimed at insured patients.